{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:18:18Z","timestamp":1787008698288,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T00:00:00Z","timestamp":1563667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"International PhD Program in Cardiovascular Pathophysiology and Therapeutics CardioPath"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study assessed the impact of the strain-guided therapeutic approach on cancer therapy-related cardiac dysfunction (CTRCD) and rate of cancer therapy (CT) interruption in breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled 116 consecutive female patients with HER2-positive breast cancer undergoing a standard protocol by EC (epirubicine + cyclophosphamide) followed by paclitaxel + trastuzumab (TRZ). Coronary artery, valvular and congenital heart disease, heart failure, primary cardiomyopathies, permanent or persistent atrial fibrillation, and inadequate echo-imaging were exclusion criteria. Patients underwent an echo-Doppler exam with determination of ejection fraction (EF) and global longitudinal strain (GLS) at baseline and every 3\u2009months during CT. All patients developing subclinical (GLS drop &gt;15%) or overt CTRCD (EF reduction &lt;50%) initiated cardiac treatment (ramipril+ carvedilol). In the 99.1% (115\/116) of patients successfully completing CT, GLS and EF were significantly reduced and E\/e\u2032 ratio increased at therapy completion. Combined subclinical and overt CTRCD was diagnosed in 27 patients (23.3%), 8 at the end of EC and 19 during TRZ courses. Of these, 4 (3.4%) developed subsequent overt CTRCD and interrupted CT. By cardiac treatment, complete EF recovery was observed in two of these patients and partial recovery in one. These patients with EF recovery re-started and successfully completed CT. The remaining patient, not showing EF increase, permanently stopped CT. The other 23 patients with subclinical CTRCD continued and completed CT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the usefulness of \u2018strain oriented\u2019 approach in reducing the rate of overt CTRCD and CT interruption by a timely cardioprotective treatment initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jez194","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T15:08:44Z","timestamp":1562166524000},"page":"1345-1352","source":"Crossref","is-referenced-by-count":56,"title":["Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction"],"prefix":"10.1093","volume":"20","author":[{"given":"Ciro","family":"Santoro","sequence":"first","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"},{"name":"Mediterranea Cardio Centro, Naples, Via Orazio 2, 80122, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lembo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Sorrentino","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"De Santo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Federico II University Hospital Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Luciano","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Casciano","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Federico II University Hospital Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Federico II University Hospital Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[{"name":"University of Li\u00e8ge Hospital, GIGA Cardiovascular Sciences, Li\u00e8ge, Belgium"},{"name":"Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Arpino","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Federico II University Hospital Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0311-9069","authenticated-orcid":false,"given":"Maurizio","family":"Galderisi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University Hospital Naples, Via Pansini 5, 80131Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,21]]},"reference":[{"key":"2019112104003630800_jez194-B1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"2019112104003630800_jez194-B2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"2019112104003630800_jez194-B3","doi-asserted-by":"crossref","first-page":"620.","DOI":"10.1038\/nrcardio.2015.133","article-title":"Cardiotoxicity of anticancer treatments","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2019112104003630800_jez194-B4","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"2019112104003630800_jez194-B5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2459\/JCM.0000000000000376","article-title":"Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy","volume":"17","author":"Madeddu","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"2019112104003630800_jez194-B7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2019112104003630800_jez194-B8","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2019112104003630800_jez194-B9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2019112104003630800_jez194-B10","first-page":"392","article-title":"Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity","volume":"18","author":"Charbonnel","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ehjci\/jey108","article-title":"Prominent longitudinal strain reduction of left ventricular basal segments in treatment-na\u00efve Anderson-Fabry disease patients","volume":"20","author":"Esposito","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/HJH.0000000000000906","article-title":"Impact of pulse pressure on left ventricular global longitudinal strain in normotensive and newly diagnosed, untreated hypertensive patients","volume":"34","author":"Lembo","year":"2016","journal-title":"J Hypertens"},{"key":"2019112104003630800_jez194-B13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0735-1097(92)90385-Z","article-title":"Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight","volume":"20","author":"de Simone","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2019112104003630800_jez194-B16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the Evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B17","first-page":"1390","article-title":"Normal reference values of multilayer longitudinal strain according to age decades in a healthy population: a single-centre experience","volume":"19","author":"Alcidi","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)00748-8","article-title":"Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy","volume":"36","author":"Cardinale","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2019112104003630800_jez194-B19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/annonc\/mdf170","article-title":"Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy","volume":"13","author":"Cardinale","year":"2002","journal-title":"Ann Oncol"},{"key":"2019112104003630800_jez194-B20","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"2019112104003630800_jez194-B21","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2019112104003630800_jez194-B22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365513.2014.898325","article-title":"TnI-Ultra assay measurements in cancer patients: comparison with the conventional assay and clinical implication","volume":"74","author":"Salvatici","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"key":"2019112104003630800_jez194-B23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ehjci\/jex033","article-title":"2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility","volume":"18","author":"Santoro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.echo.2015.06.011","article-title":"Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI\/ASE Inter-Vendor Comparison Study","volume":"28","author":"Farsalinos","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2019112104003630800_jez194-B25","first-page":"968","article-title":"Strain and left ventricular volumes for predicting cardiotoxicity: a life-saving approach in anthracycline cancer treatment?","volume":"16","author":"Bergler-Klein","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/HJH.0000000000000920","article-title":"Global longitudinal strain: a novel hallmark of cardiac risk in arterial hypertension","volume":"34","author":"Galderisi","year":"2016","journal-title":"J Hypertens"},{"key":"2019112104003630800_jez194-B27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam","year":"2014","journal-title":"Heart"},{"key":"2019112104003630800_jez194-B28","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2019112104003630800_jez194-B29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"2019112104003630800_jez194-B30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ehjci\/jet159","article-title":"Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection","volume":"15","author":"Negishi","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B32","first-page":"CD006243","article-title":"Trastuzumab containing regimens for early breast cancer","volume":"4","author":"Moja","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2019112104003630800_jez194-B33","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","article-title":"Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes (SUCCOUR) trial","volume":"11","author":"Negishi","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2019112104003630800_jez194-B34","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.cardfail.2007.06.634","article-title":"Superior detection of cardiotoxicity during chemotherapy using biomarkers","volume":"13","author":"Lenihan","year":"2007","journal-title":"J Card Fail"},{"key":"2019112104003630800_jez194-B35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cardfail.2016.03.016","article-title":"Biomarkers as predictors of cardiac toxicity from targeted cancer therapies","volume":"22","author":"Witteles","year":"2016","journal-title":"J Card Fail"},{"key":"2019112104003630800_jez194-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/20\/12\/1345\/31063535\/jez194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/20\/12\/1345\/31063535\/jez194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T04:01:19Z","timestamp":1574308879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/20\/12\/1345\/5536653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,21]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,7,21]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jez194","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,7,21]]}}}